Peer Review reports
From: 5α-reductase inhibitors impact prognosis of urothelial carcinoma
| Original Submission | ||
|---|---|---|
| 10 Apr 2020 | Submitted | Original manuscript |
| 16 Apr 2020 | Author responded | Author comments - Chien Sheng Wang |
| Resubmission - Version 2 | ||
| 16 Apr 2020 | Submitted | Manuscript version 2 |
| 27 Jun 2020 | Reviewed | Reviewer Report |
| 28 Jun 2020 | Reviewed | Reviewer Report |
| 15 Jul 2020 | Reviewed | Reviewer Report - Niveditha Nerlakanti |
| 6 Aug 2020 | Author responded | Author comments - Chien Sheng Wang |
| Resubmission - Version 3 | ||
| 6 Aug 2020 | Submitted | Manuscript version 3 |
| 15 Aug 2020 | Reviewed | Reviewer Report |
| 30 Aug 2020 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 1 Sep 2020 | Editorially accepted | |
| 11 Sep 2020 | Article published | 10.1186/s12885-020-07373-4 |
You can find further information about peer review here.